Sort   by:  
 Page size 
UnknownTisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
Not available
S-EPMC10730069 | biostudies-literature
UnknownTALEN-mediated apc mutation in Xenopus tropicalis phenocopies familial adenomatous polyposis.
Not available
S-EPMC4468341 | biostudies-literature
UnknownLoss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.
Not available
S-EPMC6500912 | biostudies-literature
UnknownA phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
Not available
S-EPMC10982620 | biostudies-literature
UnknownDurvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Not available
S-EPMC10824389 | biostudies-literature
UnknownHigh-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Not available
S-EPMC8268616 | biostudies-literature
UnknownMethylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.
Not available
S-EPMC5481993 | biostudies-literature
UnknownTRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma.
Not available
S-EPMC8732886 | biostudies-literature
UnknownCancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines.
Not available
S-EPMC7322604 | biostudies-literature
UnknownDeveloping Organoids from Ovarian Cancer as Experimental and Preclinical Models.
Not available
S-EPMC7160357 | biostudies-literature
Sort   by:  
 Page size